Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: SHORT OF BREATH; FATIGUE; HEADACHE; GENERALISED ACHING; This spontaneous report received from a patient concerned a 33 year old female. The patient''s height, and weight were not reported. The patient''s pre-existing medical conditions included the patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: ibuprofen. On 11-APR-2021, the subject experienced generalised aching. On 24-APR-2021, the subject experienced short of breath. On 24-APR-2021, the subject experienced fatigue. On 24-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from generalised aching on 12-APR-2021, and had not recovered from fatigue, headache, and short of breath. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166